Susan is ready for a new adventure after the Vertiflex™ procedure

Twelve years ago, Arizonan Susan McDowell, 73, began to experience back pain that interfered with her ability to hike, golf, ski or even walk.

Read more about Susan's story

Featured stories

Learn how this new initiative will reduce our carbon footprint and get products to patients more reliably.

This innovative technology, just approved by the FDA, offers patients faster, more controlled healing than its predecessor.

Hear from three employees whose devotion to STEM education is making a difference around the globe.

Read more stories

Press releases
Sep 19, 2023

Acquisition intended to expand neuromodulation portfolio to provide more treatment options for people living with chronic low back pain MARLBOROUGH, Mass., Sept. 19, 2023 /PRNewswire/ -- Boston...

Sep 6, 2023

New stroke risk reduction therapy with thromboresistant coating is designed to advance procedural performance and safety MARLBOROUGH, Mass., Sept. 6, 2023 /PRNewswire/ -- Boston Scientific...

Sep 5, 2023

Boston Scientific Corporation (NYSE: BSX) will host a meeting with the investor community to review its financial goals and long-term growth strategies on Wednesday, September 20, 2023, between...

Read more press releases

In the news
Dec 16, 2023
Women Inc.
If you’re looking to advance your career, Mary Beth Moynihan, senior vice president of market access and chief marketing officer, has three words for you: “You’re worth it.”
Jun 5, 2023
Medical Design and Outsourcing
Boston Scientific’s market capitalization has grown nearly 10 times larger since Mike Mahoney joined as CEO in 2011. He shared key insights about corporate strategy at DeviceTalks Boston in May.
May 25, 2023
Health Tech World
Eric Thépaut, executive vice president and president, Europe, Middle East and Africa, shares how digital education platforms, real-time and on-demand technologies and remote case support are being utilized to help patients.
May 22, 2023
MassDevice
Data supporting use of key Boston Scientific electrophysiology and cardiac rhythm management therapies, and the WATCHMAN FLX™ Left Atrial Appendage Closure Device were presented at Heart Rhythm 2023, the annual meeting of the Heart Rhythm Society.

Read more news

2022 Performance Report

When science, humanity and purpose connect, lives can be transformed

View the Report

Sign up to receive our press releases via email

Business and enterprise contacts for journalists

Imagery and other resources

Top